These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 9828206

  • 1. Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans.
    Thimister PW, Hopman WP, Tangerman A, Rosenbusch G, Willems HL, Jansen JB.
    Hepatology; 1998 Dec; 28(6):1454-60. PubMed ID: 9828206
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exocrine pancreatic secretion and plasma levels of cholecystokinin, pancreatic polypeptide, and somatostatin after single and combined intraduodenal application of different bile salts in man.
    Riepl RL, Fiedler F, Kowalski C, Teufel J, Lehnert P.
    Ital J Gastroenterol; 1996 Dec; 28(8):421-9. PubMed ID: 9032583
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man.
    Regan PT, Go VL, DiMagno EP.
    J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959
    [Abstract] [Full Text] [Related]

  • 7. Effect of cadmium and bombesin on exocrine pancreatic secretions and plasma levels of gastrin and cholecystokinin (CCK) in rats.
    Chowdhury P, Ami M, Rayford PL.
    Ann Clin Lab Sci; 1986 Oct; 16(6):479-87. PubMed ID: 3800302
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
    Cantor P, Mortensen PE, Myhre J, Gjorup I, Worning H, Stahl E, Survill TT.
    Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
    [Abstract] [Full Text] [Related]

  • 10. Role of intraduodenal proteases in plasma cholecystokinin and pancreaticobiliary responses to protein and amino acids.
    Thimister PW, Hopman WP, Sloots CE, Rosenbusch G, Willems HL, Trijbels FJ, Jansen JB.
    Gastroenterology; 1996 Feb; 110(2):567-75. PubMed ID: 8566605
    [Abstract] [Full Text] [Related]

  • 11. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P, Beglinger C, Gyr K, Jansen JB, Rovati LC, Zuercher M, Lamers CB, Setnikar I, Stalder GA.
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [Abstract] [Full Text] [Related]

  • 12. Pancreatic, gallbladder, and gastric responses to intraduodenal calcium perfusion in man.
    Holtermuller KH, Mallagelada JR, McCall JT, Go VL.
    Gastroenterology; 1976 May; 70(5 PT.1):693-6. PubMed ID: 1261760
    [Abstract] [Full Text] [Related]

  • 13. Effect of intragastric or intraduodenal administration of a polymeric diet on gallbladder motility, small-bowel transit time, and hormone release.
    Ledeboer M, Masclee AA, Biemond I, Lamers CB.
    Am J Gastroenterol; 1998 Nov; 93(11):2089-96. PubMed ID: 9820378
    [Abstract] [Full Text] [Related]

  • 14. Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion.
    Thimister PW, Hopman WP, Loualidi A, Rosenbusch G, Willems HL, Trijbels FJ, Jansen JB.
    Scand J Gastroenterol; 1997 Aug; 32(8):778-84. PubMed ID: 9282969
    [Abstract] [Full Text] [Related]

  • 15. Mediators of exocrine pancreatic secretion induced by intraduodenal application of bile and taurodeoxycholate in man.
    Riepl RL, Reichardt B, Rauscher J, Tzavella K, Teufel J, Lehnert P.
    Eur J Med Res; 1997 Jan; 2(1):23-9. PubMed ID: 9049590
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function.
    Tachibana I, Kanagawa K, Yamamoto Y, Otsuki M.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1404-12. PubMed ID: 8968365
    [Abstract] [Full Text] [Related]

  • 17. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans.
    Mitsukawa T, Takemura J, Nishizono F, Nakatsuru K, Ohgo S, Matsukura S.
    Am J Gastroenterol; 1989 Nov; 84(11):1371-4. PubMed ID: 2683738
    [Abstract] [Full Text] [Related]

  • 18. Interactions between intraluminal bile acids and digestive products on pancreatic and gallbladder function.
    Malagelada JR, Go VL, DiMagno EP, Summerskill WH.
    J Clin Invest; 1973 Sep; 52(9):2160-5. PubMed ID: 4727454
    [Abstract] [Full Text] [Related]

  • 19. Effect of bile salt binding or protease inactivation on plasma cholecystokinin and gallbladder responses to bombesin.
    Thimister PW, Hopman WP, Sloots CE, Rosenbusch G, Tangerman A, Willems HL, Lamers CB, Jansen JB.
    Gastroenterology; 1994 Dec; 107(6):1627-35. PubMed ID: 7958672
    [Abstract] [Full Text] [Related]

  • 20. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE, Creutzfeldt W, Schleser A, Choudhury AR, Nustede R, Höcker M, Nitsche R, Sostmann H, Rovati LC, Fölsch UR.
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.